Extending AAV Packaging Cargo through Dual Co-Transduction: Efficient Protein Trans-Splicing at Low Vector Doses
-
Published:2023-06-23
Issue:13
Volume:24
Page:10524
-
ISSN:1422-0067
-
Container-title:International Journal of Molecular Sciences
-
language:en
-
Short-container-title:IJMS
Author:
Ferreira Mariana V.12ORCID,
Fernandes Sofia12,
Almeida Ana Isabel12,
Neto Salomé12,
Mendes João P.12,
Silva Ricardo J. S.12ORCID,
Peixoto Cristina12,
Coroadinha Ana Sofia12ORCID
Affiliation:
1. iBET-Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2781-901 Oeiras, Portugal
2. Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. da República, 2780-157 Oeiras, Portugal
Abstract
Adeno-associated viral (AAV) vectors represent one of the leading platforms for gene delivery. Nevertheless, their small packaging capacity restricts their use for diseases requiring large-gene delivery. To overcome this, dual-AAV vector systems that rely on protein trans-splicing were developed, with the split-intein Npu DnaE among the most-used. However, the reconstitution efficiency of Npu DnaE is still insufficient, requiring higher vector doses. In this work, two split-inteins, Cfa and Gp41-1, with reportedly superior trans-splicing were evaluated in comparison with Npu DnaE by transient transfections and dual-AAV in vitro co-transductions. Both Cfa and Gp41-1 split-inteins enabled reconstitution rates that were over two-fold higher than Npu DnaE and 100% of protein reconstitution. The impact of different vector preparation qualities in split-intein performances was also evaluated in co-transduction assays. Higher-quality preparations increased split-inteins’ performances by three-fold when compared to low-quality preparations (60–75% vs. 20–30% full particles, respectively). Low-quality vector preparations were observed to limit split-gene reconstitutions by inhibiting co-transduction. We show that combining superior split-inteins with higher-quality vector preparations allowed vector doses to be decreased while maintaining high trans-splicing rates. These results show the potential of more-efficient protein-trans-splicing strategies in dual-AAV vector co-transduction, allowing the extension of its use to the delivery of larger therapeutic genes.
Funder
Fundação para a Ciência e Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior
the Associate Laboratory LS4FUTURE
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference43 articles.
1. US Food and Drug Administration (2023, April 08). FDA Approves First Gene Therapy to Treat Adults with Hemophilia B, Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-hemophilia-b.
2. Intein-Mediated Protein Trans-Splicing Expands Adeno-Associated Virus Transfer Capacity in the Retina;Tornabene;Sci. Transl. Med.,2019
3. (2020, March 16). The Jornal of Gene Medicine Gene Therapy Clinical Trails Worldwide. Available online: www.wiley.com/legacy/wileychi/genmed/clinical/.
4. Effective Delivery of Large Genes to the Retina by Dual AAV Vectors;Trapani;EMBO Mol. Med.,2014
5. Dual Adeno-Associated Virus Vectors Result in Efficient in Vitro and in Vivo Expression of an Oversized Gene, MYO7A;Dyka;Hum. Gene Ther. Methods,2014
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献